Cite
HARVARD Citation
Brik, R. et al. (2013). OP0075 A 6-Month, Phase 2, Open–Label, Single-Arm Study to Evaluate the Safety and Efficacy of Treatment with Canakinumab of Pediatric Patients with Colchicine Resistant Familial Mediterranean Fever. Annals of the rheumatic diseases. pp. A75-A76. [Online].